Germany's health insurance associations can set drug prices, EU court saysBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7442.730-c (Published 25 March 2004) Cite this as: BMJ 2004;328:730
- Jane Burgermeister
The European Court of Justice has ruled that Germany's state health insurance associations are entitled to set the maximum price that they will pay for drugs.
Europe's highest court, which is based in Luxembourg, said that Germany's system, in which state health insurance associations can determine a price ceiling for drugs does not break EU laws on competition. This is because such associations cannot be considered to be companies operating in the free market but rather …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial